| Title |
Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
|
|---|---|
| Published in |
Graefe's Archive for Clinical and Experimental Ophthalmology, August 2009
|
| DOI | 10.1007/s00417-009-1156-9 |
| Pubmed ID | |
| Authors |
Luis Javier Hernández-Pastor, Ana Ortega, Alfredo García-Layana, Joaquín Giráldez |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Germany | 1 | 2% |
| Unknown | 48 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 20% |
| Student > Master | 9 | 18% |
| Student > Ph. D. Student | 7 | 14% |
| Student > Bachelor | 6 | 12% |
| Other | 5 | 10% |
| Other | 4 | 8% |
| Unknown | 9 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 30% |
| Agricultural and Biological Sciences | 6 | 12% |
| Economics, Econometrics and Finance | 6 | 12% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Nursing and Health Professions | 3 | 6% |
| Other | 7 | 14% |
| Unknown | 10 | 20% |